ZEB2塑造动脉粥样硬化的表观遗传景观
研究通过CRISPR-Cas9基因组和表观基因组编辑,鉴定2q22.3区域冠心病GWAS信号因果基因为ZEB2。Zeb2通过染色质重塑调控平滑肌细胞表型转换,影响Notch和TGF-β信号,其缺失加速软骨样细胞形成,模拟人类高风险斑块特征。
要点
- 2q22.3区域冠心病遗传信号位于平滑肌细胞ZEB2长距离增强子内。
- Zeb2通过染色质重塑调控平滑肌细胞表型转换,影响Notch和TGF-β信号。
- 平滑肌细胞特异性Zeb2缺失加速软骨样细胞形成,模拟高风险斑块。
核心结论
- ZEB2是新的冠心病GWAS基因,通过直接影响表观基因组影响斑块易损性,提供靶向血管疾病的新治疗途径。
研究设计与样本
- 采用CRISPR-Cas9基因组和表观基因组编辑鉴定2q22.3区域冠心病变异因果基因和细胞。
- 利用小鼠模型和人类冠状动脉平滑肌细胞的单细胞表观遗传和转录组分析解析机制。
主要发现
- 2q22.3区域复杂冠心病遗传信号位于平滑肌长距离增强子内,调控ZEB2。
- Zeb2通过染色质重塑消除可及性并破坏Notch和TGF-β信号,改变平滑肌细胞转换的表观遗传轨迹。
- 平滑肌细胞特异性Zeb2缺失导致转换细胞无法关闭收缩程序并呈现成纤维细胞样表型,但加速软骨样细胞形成,模拟人类冠状动脉高风险斑块特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smooth muscle cells (SMCs) transition into a number of different phenotypes during atherosclerosis, including those that resemble fibroblasts and chondrocytes, and make up the majority of cells in the atherosclerotic plaque. To better understand the epigenetic and transcriptional mechanisms that mediate these cell state changes, and how they relate to risk for coronary artery disease (CAD), we have investigated the causality and function of transcription factors at genome-wide associated loci. METHODS: We used CRISPR-Cas 9 genome and epigenome editing to identify the causal gene and cells for a complex CAD genome-wide association study signal at 2q22.3. Single-cell epigenetic and transcriptomic profiling in murine models and human coronary artery smooth muscle cells were used to understand the cellular and molecular mechanism by which this CAD risk gene exerts its function. RESULTS: CRISPR-Cas 9 genome and epigenome editing showed that the complex CAD genetic signals within a genomic region at 2q22.3 lie within smooth muscle long-distance enhancers for ZEB2, a transcription factor extensively studied in the context of epithelial mesenchymal transition in development of cancer. Zeb2 regulates SMC phenotypic transition through chromatin remodeling that obviates accessibility and disrupts both Notch and transforming growth factor β signaling, thus altering the epigenetic trajectory of SMC transitions. SMC-specific loss of Zeb2 resulted in an inability of transitioning SMCs to turn off contractile programing and take on a fibroblast-like phenotype, but accelerated the formation of chondromyocytes, mirroring features of high-risk atherosclerotic plaques in human coronary arteries. CONCLUSIONS: These studies identify ZEB2 as a new CAD genome-wide association study gene that affects features of plaque vulnerability through direct effects on the epigenome, providing a new therapeutic approach to target vascular disease.
引用
- Cheng P, Wirka RC, Shoa Clarke L, et al. ZEB2 Shapes the Epigenetic Landscape of Atherosclerosis. Circulation. 2022. PMID: 34990206. doi:10.1161/CIRCULATIONAHA.121.057789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。